Markets:

Overview

News

Currencies

International

Treasuries

Geron Corporation - Common Stock (NQ:GERN)

0.9601 -0.1199 (-11.10%)

Delayed Quote Updated: 11:35 AM EST, Nov 5, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Geron Corporation - Common Stock

< Previous 1 2 3 4 5 6 7 Next >

Geron: 3 Key Takeaways for Long-Term Investors ↗

Today 7:14 EST

Operating expenses fell 9% year to date, and $339 million in cash leaves Geron room to pursue hematology deals.

Via The Motley Fool

Topics Earnings

Geron Corp (GERN) Q3 2026 Earnings Call Transcript ↗

November 04, 2026

First profit as a commercial-stage biotech, on RYTELO growth and cost cuts.

Via The Motley Fool

Topics Earnings

Geron Q3 Earnings Call Highlights ↗

November 04, 2026

Geron (NASDAQ:GERN) reported third-quarter net product revenue of $60.1 million for RYTELO, a 27% increase from $47.2 million a year earlier, as the company cited continued growth in prescribing,...

Via MarketBeat

Topics Earnings

Geron (NASDAQ:GERN) Falls After Mixed Q2 Results; Revenue Beats but Loss Wider Than Expected ↗

August 05, 2026

Via Chartmill

Geron Corp. (NASDAQ:GERN) Beats Q1 Estimates as RYTELO Sales Momentum Continues ↗

May 06, 2026

Via Chartmill

Geron Corp (NASDAQ:GERN) Stock Plummets 10% After Q4 Revenue Miss ↗

February 25, 2026

Via Chartmill

Earnings Scheduled For November 5, 2025 ↗

November 05, 2025

Via Benzinga

Geron Earnings Preview ↗

November 04, 2025

Via Benzinga

Most Active Stocks in the 2026-10-28 US Session ↗

October 28, 2026

Via Chartmill

Geron Eyes High End of 2026 RYTELO Revenue Guidance as Community Adoption Expands ↗

September 16, 2026

Geron (NASDAQ:GERN) executives said the company remains on track to generate 2026 RYTELO net revenue of $220 million to $240 million, with Chief Executive Officer Harout Semerjian saying the company...

Via MarketBeat

Geron Sees RYTELO Revenue Near High End of 2026 Guidance as Community Use Expands ↗

September 13, 2026

Geron (NASDAQ:GERN) said it expects full-year net revenue from RYTELO to land in the mid-to-high end of its previously stated range, or approximately $230 million to $240 million, as the company...

Via MarketBeat

Geron (GERN) Q2 2026 Earnings Call Transcript ↗

August 06, 2026

RYTELO demand grew 5% as prescribing accounts hit 1,575 since launch.

Via The Motley Fool

Topics Earnings

Earnings Scheduled For August 6, 2025 ↗

August 06, 2025

Via Benzinga

Earnings Scheduled For May 7, 2025 ↗

May 07, 2025

Via Benzinga

Why Geron Stock Is Plummeting Today ↗

February 26, 2025

Via The Motley Fool

Geron Q2 Earnings Call Highlights ↗

August 05, 2026

Geron (NASDAQ:GERN) reported second-quarter net revenue of $57.5 million, up 17% from a year earlier and 11% sequentially, as the company continued to expand use of RYTELO among patients with...

Via MarketBeat

Topics Earnings

Geron (GERN) Q1 2026 Earnings Call Transcript ↗

May 07, 2026

Geron (GERN) Q1 2026 Earnings Call Transcript

Via The Motley Fool

Topics Earnings Economy

Here are the top movers in Wednesday's session. ↗

February 25, 2026

Via Chartmill

Geron (GERN) Q4 2025 Earnings Call Transcript ↗

February 25, 2026

Geron (GERN) Q4 2025 Earnings Call Transcript

Via The Motley Fool

Topics Earnings

Which stocks are moving before the opening bell on Wednesday? ↗

February 25, 2026

Via Chartmill

Why Did GERN Stock Tumble 10% Pre-Market Today? ↗

February 25, 2026

Total revenue reached $48 million for the fourth-quarter with a loss per share (EPS) of $0.05, with both metrics coming in below street estimates.

Via Stocktwits

Topics Artificial Intelligence

Geron Corp (NASDAQ:GERN) Reports Mixed Q3 2025 Results, Misses Revenue Estimates ↗

November 05, 2025

Geron's Q3 2025 results show mixed performance, with RYTELO revenue up 67% year-over-year but missing analyst sales estimates, causing a negative market reaction.

Via Chartmill

Geron (GERN) Q2 Revenue Jumps 5,477% ↗

August 06, 2025

Via The Motley Fool

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

August 06, 2025

Via Benzinga

Why Geron Stock Crept Higher Today ↗

May 07, 2025

Via The Motley Fool

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

May 07, 2025

Via Benzinga

10 Health Care Stocks Whale Activity In Today's Session ↗

March 21, 2025

Via Benzinga

What's going on in today's session ↗

February 26, 2025

Wondering how the US markets performed one hour before the close of the markets on Wednesday? Discover the movers and shakers of today's session in our comprehensive analysis.

Via Chartmill

Dow Dips Over 100 Points; TJX Earnings Top Views ↗

February 26, 2025

Via Benzinga

Topics Stocks

Here are the top movers in Wednesday's session. ↗

February 26, 2025

Stay up-to-date with the latest market trends in the middle of the day on Wednesday. Explore the top gainers and losers during today's session in our detailed report.

Via Chartmill

< Previous 1 2 3 4 5 6 7 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.